FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2325775796> ?p ?o ?g. }

• W2325775796 abstract "While therapeutic strategies have improved, ∼500,000 women worldwide die from breast cancer each year. Many proteins have been implicated in breast cancer, including the HER family of receptors. Overexpression of epidermal growth factor receptor (EGFR) and one of its family members, HER2, each occur in ∼30% of breast cancers and correlates with poor clinical prognosis. Herceptin, an inhibitor of HER2, has been approved for treatment of breast cancer patients; however small molecule tyrosine kinase inhibitors (TKIs) targeting EGFR have not shown efficacy in breast cancer. To understand why breast cancers do not respond to EGFR tyrosine kinase inhibition, a panel of twenty breast cancer cell lines was characterized for EGFR expression. Thirteen of the twenty cell lines expressed EGFR; seven of which were resistant to EGFR TKIs. Unlike the response of HER2 positive breast cancers to Herceptin, increased expression of EGFR correlated with resistance to EGFR TKIs. One possible mechanism for resistance to EGFR TKIs is that EGFR expression is not required for growth. However, when EGFR expression was knocked down, cell growth was significantly decreased in four of the seven cell lines suggesting that EGFR expression is important for cell growth in a portion of EGFR TKI resistant breast cancers. A second mechanism for resistance to EGFR may be elevated HER2 and HER3 expression as observed in lung cancer. Conversely, in these cell lines, HER2 and HER3 expression levels did not correlate with response to EGFR TKIs. In addition, an EGFR family kinase inhibitor also was unable to abrogate the growth of these cells suggesting that HER2 expression and kinase activity was not a mediator of cell growth in the presence of EGFR TKIs. EGFR is known to localize within many sub-cellular regions including the nucleus, mitochondria, endosomes, and plasma membrane. Localization of EGFR to membrane microdomains (lipid rafts) is known to modulate EGFR signaling. Therefore, a third potential mechanism for EGFR TKI resistance may be localization of EGFR within lipid rafts. Using biochemical raft isolation and immunofluorescence, EGFR was shown to localize to lipid rafts in all four EGFR-dependent, EGFR TKI resistant breast cancer cell lines. To determine if this localization mediates resistance to EGFR TKIs, cholesterol (a main structural component of lipid rafts) was depleted using cholesterol biosynthesis inhibitors. While such inhibitors had no effect on cell growth alone, combinatorial depletion of lipid rafts and inhibition of EGFR-kinase activity resulted in decreased cell growth. Further, the interaction between cholesterol biosynthesis inhibitors and EGFR inhibitors was synergistic. Thus, we have discovered that EGFR expression and localization to lipid rafts correlate with EGFR TKI resistance in breast cancer, and that depletion of lipid rafts can overcome such resistance in EGFR expression-dependent breast cancer cells. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 269." @default.
• W2325775796 created "2016-06-24" @default.
• W2325775796 creator A5044158880 @default.
• W2325775796 creator A5077114224 @default.
• W2325775796 creator A5085966748 @default.
• W2325775796 date "2010-04-15" @default.
• W2325775796 modified "2023-09-27" @default.
• W2325775796 title "Abstract 269: Disruption of lipid rafts sensitizes EGFR expressing breast cancer cells to EGFR inhibitors" @default.
• W2325775796 doi "https://doi.org/10.1158/1538-7445.am10-269" @default.
• W2325775796 hasPublicationYear "2010" @default.
• W2325775796 type Work @default.
• W2325775796 sameAs 2325775796 @default.
• W2325775796 citedByCount "0" @default.
• W2325775796 crossrefType "proceedings-article" @default.
• W2325775796 hasAuthorship W2325775796A5044158880 @default.
• W2325775796 hasAuthorship W2325775796A5077114224 @default.
• W2325775796 hasAuthorship W2325775796A5085966748 @default.
• W2325775796 hasConcept C121608353 @default.
• W2325775796 hasConcept C126322002 @default.
• W2325775796 hasConcept C170493617 @default.
• W2325775796 hasConcept C2776256026 @default.
• W2325775796 hasConcept C2777506169 @default.
• W2325775796 hasConcept C2779438470 @default.
• W2325775796 hasConcept C42362537 @default.
• W2325775796 hasConcept C502942594 @default.
• W2325775796 hasConcept C530470458 @default.
• W2325775796 hasConcept C71924100 @default.
• W2325775796 hasConceptScore W2325775796C121608353 @default.
• W2325775796 hasConceptScore W2325775796C126322002 @default.
• W2325775796 hasConceptScore W2325775796C170493617 @default.
• W2325775796 hasConceptScore W2325775796C2776256026 @default.
• W2325775796 hasConceptScore W2325775796C2777506169 @default.
• W2325775796 hasConceptScore W2325775796C2779438470 @default.
• W2325775796 hasConceptScore W2325775796C42362537 @default.
• W2325775796 hasConceptScore W2325775796C502942594 @default.
• W2325775796 hasConceptScore W2325775796C530470458 @default.
• W2325775796 hasConceptScore W2325775796C71924100 @default.
• W2325775796 hasLocation W23257757961 @default.
• W2325775796 hasOpenAccess W2325775796 @default.
• W2325775796 hasPrimaryLocation W23257757961 @default.
• W2325775796 hasRelatedWork W1984871551 @default.
• W2325775796 hasRelatedWork W1995302565 @default.
• W2325775796 hasRelatedWork W2011026203 @default.
• W2325775796 hasRelatedWork W2060723055 @default.
• W2325775796 hasRelatedWork W2093584358 @default.
• W2325775796 hasRelatedWork W2123441822 @default.
• W2325775796 hasRelatedWork W2126877198 @default.
• W2325775796 hasRelatedWork W2163252214 @default.
• W2325775796 hasRelatedWork W2174033131 @default.
• W2325775796 hasRelatedWork W2252667083 @default.
• W2325775796 hasRelatedWork W2553214361 @default.
• W2325775796 hasRelatedWork W2738168560 @default.
• W2325775796 hasRelatedWork W2767958439 @default.
• W2325775796 hasRelatedWork W2903663139 @default.
• W2325775796 hasRelatedWork W3031847271 @default.
• W2325775796 hasRelatedWork W3034951790 @default.
• W2325775796 hasRelatedWork W3035982534 @default.
• W2325775796 hasRelatedWork W3165970231 @default.
• W2325775796 hasRelatedWork W3199605758 @default.
• W2325775796 hasRelatedWork W3203283759 @default.
• W2325775796 isParatext "false" @default.
• W2325775796 isRetracted "false" @default.
• W2325775796 magId "2325775796" @default.
• W2325775796 workType "article" @default.